Tag : Backed

CCT Impact

PURA Backed By UCASU Targets $10M In 2022 Revenue From New Hemp Business

CCT IMPACT Agent
Puration, Inc. (USOTC: PURA) today announced the company will publish a strategic overview presentation next week on Tuesday, January 18th covering the company’s 2022 plan to achieve a forecasted $1 million in revenue and reach for a potential $10 million in revenue.  The presentation will include the latest on PURA’s backing from UC Asset LP (OTCQX: UCASU)......
CCT Impact

PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

CCT IMPACT Agent
PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive......